Endothelial dysfunction and lung capillary injury in cardiovascular diseases

Marco Guazzi, Shane A. Phillips, Ross Arena, Carl J. Lavie

Research output: Contribution to journalArticle

Abstract

Cardiac dysfunction of both systolic and diastolic origins leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolar-capillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitation and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.

Original languageEnglish
Pages (from-to)454-462
Number of pages9
JournalProgress in Cardiovascular Diseases
Volume57
Issue number5
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Lung Injury
Cardiovascular Diseases
Gases
Extracellular Matrix
Heart Failure
Pressure
Lung
Atrial Pressure
Myofibroblasts
Angiotensin-Converting Enzyme Inhibitors
Permeability
Nitric Oxide
Fibrosis
Arteries
Air
Exercise
Membranes
Wounds and Injuries
Therapeutics

Keywords

  • Alveolar-capillary unit
  • Endothelial dysfunction
  • Lung capillaries

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Endothelial dysfunction and lung capillary injury in cardiovascular diseases. / Guazzi, Marco; Phillips, Shane A.; Arena, Ross; Lavie, Carl J.

In: Progress in Cardiovascular Diseases, Vol. 57, No. 5, 01.03.2015, p. 454-462.

Research output: Contribution to journalArticle

Guazzi, Marco ; Phillips, Shane A. ; Arena, Ross ; Lavie, Carl J. / Endothelial dysfunction and lung capillary injury in cardiovascular diseases. In: Progress in Cardiovascular Diseases. 2015 ; Vol. 57, No. 5. pp. 454-462.
@article{a7ec46ceae2548b49a88794950483769,
title = "Endothelial dysfunction and lung capillary injury in cardiovascular diseases",
abstract = "Cardiac dysfunction of both systolic and diastolic origins leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolar-capillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitation and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.",
keywords = "Alveolar-capillary unit, Endothelial dysfunction, Lung capillaries",
author = "Marco Guazzi and Phillips, {Shane A.} and Ross Arena and Lavie, {Carl J.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.pcad.2014.11.003",
language = "English",
volume = "57",
pages = "454--462",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Endothelial dysfunction and lung capillary injury in cardiovascular diseases

AU - Guazzi, Marco

AU - Phillips, Shane A.

AU - Arena, Ross

AU - Lavie, Carl J.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Cardiac dysfunction of both systolic and diastolic origins leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolar-capillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitation and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.

AB - Cardiac dysfunction of both systolic and diastolic origins leads to increased left atrial pressure, lung capillary injury and increased resistance to gas transfer. Acutely, pressure-induced trauma disrupts the endothelial and alveolar anatomical configuration and definitively causes an impairment of cellular pathways involved in fluid-flux regulation and gas exchange efficiency, a process well identified as stress failure of the alveolar-capillary membrane. In chronic heart failure (HF), additional stimuli other than pressure may trigger the true remodeling process of capillaries and small arteries characterized by endothelial dysfunction, proliferation of myofibroblasts, fibrosis and extracellular matrix deposition. In parallel there is a loss of alveolar gas diffusion properties due to the increased path from air to blood (thickening of extracellular matrix) and loss of fine molecular mechanism involved in fluid reabsorption and clearance. Deleterious changes in gas transfer not only reflect the underlying lung tissue damage but also portend independent prognostic information and may play a role in the pathogenesis of exercise limitation and ventilatory abnormalities observed in these patients. Few currently approved treatments for chronic HF have the potential to positively affect structural remodeling of the lung capillary network; angiotensin-converting enzyme inhibitors are one of the few currently established options. Recently, more attention has been paid to novel therapies specifically targeting the nitric oxide pathway as a suitable target to improve endothelial function and permeability as well as alveolar gas exchange properties.

KW - Alveolar-capillary unit

KW - Endothelial dysfunction

KW - Lung capillaries

UR - http://www.scopus.com/inward/record.url?scp=84924767073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924767073&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2014.11.003

DO - 10.1016/j.pcad.2014.11.003

M3 - Article

C2 - 25446556

AN - SCOPUS:84924767073

VL - 57

SP - 454

EP - 462

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 5

ER -